Detection of Early Molecular Response (EMR) and Minimal Residual Disease (MRD) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Using a Validated Next Generation Sequencing (NGS) Assay for the Detection of Tumor Variants in Circulating Tumor (ct)DNA

Authors:
Open Access
Publisher website
Google Scholar
Abstract
DLBCL is the most common type of non-Hodgkin lymphoma in adults. Although frontline standard of care treatment is effective in 60-70% of patients, 10-15% have p